nach oben

Erschienen in:

01.05.2007 | Original Article

Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile

verfasst von: Sana Al-Mutairi, Adel Al-Awadhi, Raj Raghupathy, Hanaa Al-Khawari, Prio Sada, Adeebah Al-Herz, Parvez Rawoot

Erschienen in: Rheumatology International | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The literature on cytokine response in systemic lupus erythematosus (SLE) is confusing. It is possible that different disease phenotypes have different cytokine profiles. Our aim was to examine the levels of selected pro-inflammatory and anti-inflammatory cytokines in SLE patients with and without pulmonary involvement.

Methods and subjects

Patients with SLE were interviewed and were subjected to the pulmonary function test and high-resolution computed tomography studies. Serum levels of interleukin (IL)-6, IL-8, IL-10, Il-12, interferon (IFN) γ, and tumor necrosis factor (TNF) α were estimated by enzyme-linked immunosorbent assay.

Results

Forty-nine of the 61 SLE patients had pulmonary involvement. Median levels of IL-8, IFNγ, and TNFα were significantly higher in the pulmonary group as compared to the non-pulmonary group (p = 0.027, 0.027 and 0.002, respectively). Ratios of pro-inflammatory cytokines to anti-inflammatory cytokines were higher in the pulmonary group as compared to the non-pulmonary group as well as in the pulmonary restrictive subgroup compared to the obstructive subgroup.

Conclusion

Lupus patients with pulmonary involvement have a stronger pro-inflammatory cytokine bias than those without pulmonary involvement.

Korzin BL (1996) Systemic lupus erythematosus. Cell 85:303–306CrossRef

Lauwerys BR, Houssiau FA (2003) Involvement of cytokines in the pathogenesis of systemic lupus erythematosus. In: Santamaria P (ed) Cytokines and chemokines in autoimmune disease. Plenum Publishers, New York, pp 237–251

Kirou KA, Crow MK (1999) New pieces to the SLE cytokine puzzle. Clin Immunol 91:1–5PubMedCrossRef

Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA (2000) Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59:243–251PubMedCrossRef

Tam EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRef

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for Lupus patients. Arthritis Rheum 35:630–640PubMedCrossRef

Burney PGJ, Luczynska C, Chinn S, Jarvis D (1994) The European Community Respiratory Health Survey. Eur Respir J 7:954–960PubMed

The European Community Respiratory Health Survey “Medicine and Health” (1994) EC Directorate General XIII. Office for Official Publications, Luxemburg

Medical Research Council Respiratory Symptoms Questionnaire (1976) The Council, London

10.

Toren K, Brisman J, Jarvholm B (1993) Asthma and asthma-like symptoms in adults assessed by questionnaires: a literature review. Chest 104:600–608PubMed

11.

Burney PGJ, Laitinen LA, Predrizet S, Huckauf H, Tattersfield AE, Chinn S, Poisson N, Heeren A, Britton JR, Jones T (1989) Validity and repeatability of the IUATLD (1984) bronchial symptoms questionnaire: an international comparison. Eur Respir J 2:940–945PubMed

12.

Burney PGJ, Chinn S, Britton JR, Tattersfield AE, Papacosta AO (1989) What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol 18:165–173PubMedCrossRef

13.

Burney PGJ, Papacosta AO, Withey CH, Colley JRT, Holland WW (1991) Hospital admission rates and the prevalence of asthma symptoms in 20 local authority districts. Thorax 46:574–579PubMedCrossRef

14.

Jarvis D, Lai E, Luczynska C, Chinn S, Burney P (1994) Prevalence of asthma and asthma-like symptoms in young adults living in three East Anglian towns. Br J General Patrice 44:493–497

15.

Sunyer J, Basagana X, Burney P, Anto JM (2000) International assessment of the internal consistency of respiratory symptoms. European Community Respiratory Health Study (ECRHS). Am J Resp Crit Care Med 162:930–935PubMed

16.

Abramson M, Matheson M, Wharton C, Sim M, Walters HE (2002) Prevalence of respiratory symptoms related to chronic obstructive pulmonary disease and asthma among middle aged and older adults. Respirology 7:325–331PubMedCrossRef

17.

National Institute for Clinical Excellence (NICE) (2004) Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 (Suppl 1):1–232

18.

Grassi M, Villani S, Marinoni A, for ECRHS Group (2001) Classification methods for the identification of “case” in epidemiological diagnosis of asthma. Eur J Epidemiol 17:19–29PubMedCrossRef

19.

Standardization of Spirometry, 1994 Update (1995) American Thoracic Society. Am J Respir Crit Care Med 152:1107–1136

20.

British Thoracic Society, Scottish Intercollegiate Guideline Network (2003) British Guidelines on the management of asthma. Thorax 58(Suppl 1):1–94

21.

American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144:1202–1216

22.

Morimoto S, Tokano Y, Kaneko H, Nowaza K, Amano H, Hashimoto H (2001) The increased interleukin-13 in patients with systemic lupus erythematosus: relation to other Th1-, Th2-related cytokines and clinical findings. Autoimmunity 34:19–25PubMedCrossRef

23.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S (2003) Serum concentration of CXC chemokines interleukin 8 a growth-related oncogene-alpha are elevated in patients with systemic sclerosis. J Rheumatol 30:1524–1528PubMed

24.

Yoshio T, Masuyama JI, Kohda N, Hirata D, Sato H, Iwamoto M, Mimori A, Takeda A, Minota S, Kano S (1997) Association of interleukin-6 release from endothelial cells and pulmonary hypertension in SLE. J Rheumatol 24:489–495PubMed

25.

Cross JT, Benton HP (1999) The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm Res 48:255–261PubMedCrossRef

26.

Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets. Immunol Today 17:138–146PubMedCrossRef

27.

Romognani S (2000) T-cell subsets (Th1 versus Th2). Ann Aller Asthma Immunol 85:9–18

28.

Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcon-Segovia D, Wijdenes J, Galanaud P, Emilie D (2000) Clinical and biological effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43:1790–800PubMedCrossRef

29.

Tokano Y, Morimoto S, Kaneko H, Amano H, Nozawa K, Yakasaki Y, Hashimoto H (1999) Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 116:169–173PubMedCrossRef

30.

Robak E, Robak T, Wozniacka A, Zak-Prelich M, Sysa-Jedrzejowska A, Stepien H (2002) Pro-inflammatory interferon-γ-inducing monokines (interleukin-12, interleukin-18, interleukin-15)-serum profile in patients with systemic lupus erythematosus. Eur Cytokine Network 13:364–368

31.

Wong CK, Ho CY, Li EK, Lam CWK (2000) Elevation of pro-inflammatory cytokine (IL-18, IL-17, IL-12) and Th2-cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589–593PubMedCrossRef

32.

Liu TF, Jones BM (1994) Impaired production of IL-12 in systemic lupus erythematosus. II. IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFNγ and negatively with disease activity in SLE. Cytokines 10:148–153CrossRef

33.

Liu TF, Jones BM, Wong RW, Srivastava G (1999) Impaired production of IL-12 in systemic lupus erythematosus. III. Deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression. Cytokines 11:805–811CrossRef

34.

Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Oht K, Trinchieri G (1998) Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 41:838–844PubMedCrossRef

35.

Spadaro A, Scrivo R, Rinaldi T, Riccieri V, Sili Scavalli A, Taccari E, Valesini G (2002) The role of interleukin-12 in immune-mediated rheumatic diseases. Reumatismo 54:113–121PubMed

36.

Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNF alpha, p55 srTNF alpha, p75 srTNF alpha, srIL-12 alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22PubMedCrossRef

37.

Nakajima A, Hirose S, Yagita H, Okumura K (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 158:1466–1472PubMed

38.

Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-Boursier M, Ragnaud JM, Leng B, Moreau JF (1999) Th1 (IL-2, interferon-gamma IFN-gamma) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115:189–195PubMedCrossRef

39.

Sturfelt G, Roux-Lombard P, Wollheim FA, Dayer JM (1997) Low levels of interleukin-1 receptor antagonist coincides with kidney involvement in systemic lupus erythematosus. Br J Rheumatol 36:1283–1289PubMedCrossRef

40.

Holcombe RF, Baethge BA, Wolf RE, Betzing KW, Stewart RM, Hal VC, Fukuda M (1994) Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. Lupus 3:97–102PubMed

41.

Hsieh SC, Tsai CY, Sun KH, Yu HS, Tsai ST, Wang JC, Tsai YY, Han SH, Yu CL (1994) Decreased spontaneous and lipopolysaccharide stimulated production of interleukin 8 by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Clin Exp Immunol 12:627–633

42.

Hsieh SC, Yu HS, Lin WW, Sun KH, Tsai CY, Huang DF, Tsai YY, Yu CL (2003) Anti-SSB/La is one of the antineutrophil antibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 131:506–516PubMedCrossRef

43.

Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123PubMed

44.

Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S (1993) Cytokine profiles in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13:58–67PubMedCrossRef

45.

Barcellini W, Rizzardi GP, Borghi MO, Nicoletti F, Fain C, Del-Papa N, Meroni PL (1996) In vitro type-1 and type-2 cytokines production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus 5:139–145PubMed

46.

Emilie D, Llorente L, Galanaud P (1996) Cytokines and lupus. Ann Med Intern (Paris) 147:480–484

47.

Lauwerys BR, Van Snick J, Houssiau FA (2002) Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 11:384–387PubMedCrossRef

48.

Abal At, Nair MGP, Behbehani NA, Sharma PN (2001) Hospital admissions and death rates from asthma in Kuwait during pre- and post-Gulf War periods. Ann Aller Asthma Immunol 86:465–468CrossRef

49.

Behbehani NA, Abal A, Syabbalo NC, Azeem AA, Shareef E, Al-Momen J (2000) Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old children in Kuwait: an ISAAC study. Ann Allergy Asthma Immunol 85:58–63PubMed

Titel: Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile
verfasst von: Sana Al-Mutairi
Adel Al-Awadhi
Raj Raghupathy
Hanaa Al-Khawari
Prio Sada
Adeebah Al-Herz
Parvez Rawoot
Publikationsdatum: 01.05.2007
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 7/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-006-0268-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile

Abstract

Objectives

Methods and subjects

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Objectives

Methods and subjects

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2007

Adaptation of the RAQoL for use in Australia

Osteomalacia from Mg-containing antacid: a case report of bilateral hip fracture

Correlation between Yersinia enterocolitica and type I collagen reactivity in patients with arthropathies

Spontaneous pneumomediastinum and subcutaneous emphysema in systemic sclerosis

Case report of a patient with osteopoikilosis

Familial mediterranean fever unusually coexisted in an ankylosing spondylitis patient. MEFV mutation has any role?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin